PEGylated versus non-PEGylated magnetic nanoparticles as camptothecin delivery system

被引:30
作者
Castillo, Paula M. [1 ,2 ,3 ]
de la Mata, Mario [4 ]
Casula, Maria F. [1 ,2 ]
Sanchez-Alcazar, Jose A. [4 ]
Zaderenko, Ana P. [3 ]
机构
[1] Univ Cagliari, INSTM, I-09124 Cagliari, Italy
[2] Univ Cagliari, Dipartimento Sci Chim & Geol, I-09124 Cagliari, Italy
[3] Univ Pablo Olavide, Dept Sistemas Fis Quim & Nat, Seville, Spain
[4] Univ Pablo Olavide, CSIC, CABD, Ctr Andaluz Biol Desarrollo, Seville, Spain
来源
BEILSTEIN JOURNAL OF NANOTECHNOLOGY | 2014年 / 5卷
关键词
camptothecin; cancer therapy; iron oxide superparamagnetic nanoparticles; polyethylene glycol; IRON-OXIDE NANOPARTICLES; DRUG-DELIVERY; IN-VIVO; CYCLODEXTRIN-COMPLEXATION; TOPOISOMERASE-I; CONTRAST AGENTS; THERAPY; PHASE; DESIGN; CYTOTOXICITY;
D O I
10.3762/bjnano.5.144
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Camptothecin (CPT; (S)-(+)-4-ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14-(4H,12H)-dione) is a highly cytotoxic natural alkaloid that has not yet found use as chemotherapeutic agent due to its poor water-solubility and chemical instability and, as a consequence, no effective administration means have been designed. In this work, camptothecin has been successfully loaded into iron oxide superparamagnetic nanoparticles with an average size of 14 nm. It was found that surface modification of the nanoparticles by polyethylene glycol enables loading a large amount of camptothecin. While the unloaded nanoparticles do not induce apoptosis in the H460 lung cancer cell line, the camptothecin-loaded nanoparticle formulations exhibit remarkable proapoptotic activity. These results indicate that camptothecin retains its biological activity after loading onto the magnetic nanoparticles. The proposed materials represent novel materials based on naturally occurring bioactive molecules loaded onto nanoparticles to be used as chemotherapeutic formulations. The procedure seems apt to be extended to other active molecules extracted from natural products. In addition, these materials offer the potential of being further implemented for combined imaging and therapeutics, as magnetic nanoparticles are known to be multifunctional tools for biomedicine.
引用
收藏
页码:1312 / 1319
页数:8
相关论文
共 46 条
[31]   Topoisomerase I inhibitors: Review and update [J].
Rothenberg, ML .
ANNALS OF ONCOLOGY, 1997, 8 (09) :837-855
[32]   A phase I and pharmacokinetic study of pegylated camptothecin as a 1-hour infusion every 3 weeks in patients with advanced solid malignancies [J].
Rowinsky, EK ;
Rizzo, J ;
Ochoa, L ;
Takimoto, CH ;
Forouzesh, B ;
Schwartz, G ;
Hammond, LA ;
Patnaik, A ;
Kwiatek, J ;
Goetz, A ;
Denis, L ;
McGuire, J ;
Tolcher, AW .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (01) :148-157
[33]   Biomedical tools based on magnetic nanoparticles [J].
Saba, Anna R. ;
Castillo, Paula M. ;
Fantechi, Elvira ;
Sangregorio, Claudio ;
Lascialfari, Alessandro ;
Sbarbati, Andrea ;
Casu, Alberto ;
Falqui, Andrea ;
Casula, Maria F. .
COLLOIDAL NANOCRYSTALS FOR BIOMEDICAL APPLICATIONS VIII, 2013, 8595
[34]   Doxorubicin-conjugated core-shell magnetite nanoparticles as dual-targeting carriers for anticancer drug delivery [J].
Sadighian, Somayeh ;
Rostamizadeh, Kobra ;
Hosseini-Monfared, Hassan ;
Hamidi, Mehrdad .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2014, 117 :406-413
[35]   A phase II study of pegylated-camptothecin (pegamotecan) in the treatment of locally advanced and metastatic gastric and gastro-oesophageal junction adenocarcinoma [J].
Scott, L. C. ;
Yao, J. C. ;
Benson, A. B., III ;
Thomas, A. L. ;
Falk, S. ;
Mena, R. R. ;
Picus, J. ;
Wright, J. ;
Mulcahy, M. F. ;
Ajani, J. A. ;
Evans, T. R. J. .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (02) :363-370
[36]   Surface engineered magnetic nanoparticles for removal of toxic metal ions and bacterial pathogens [J].
Singh, Sarika ;
Barick, K. C. ;
Bahadur, D. .
JOURNAL OF HAZARDOUS MATERIALS, 2011, 192 (03) :1539-1547
[37]   Electrophoretic separation of nanoparticles with a discrete number of functional groups [J].
Sperling, Ralph A. ;
Pellegrino, Teresa ;
Li, Jimmy K. ;
Chang, Walter H. ;
Parak, Wolfgang J. .
ADVANCED FUNCTIONAL MATERIALS, 2006, 16 (07) :943-948
[38]   Effect of hydroxypropyl-β-cyclodextrin-complexation and pH on solubility of camptothecin [J].
Sætern, AM ;
Nguyen, NB ;
Bauer-Brandl, A ;
Brandl, M .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 284 (1-2) :61-68
[39]   Nanoparticles-mediated drug delivery approaches for cancer targeting: a review [J].
Sultana, Shaheen ;
Khan, Mohd Rashid ;
Kumar, Mukesh ;
Kumar, Sokindra ;
Ali, Mohammed .
JOURNAL OF DRUG TARGETING, 2013, 21 (02) :107-125
[40]   Clinical applications of the camptothecins [J].
Takimoto, CH ;
Wright, J ;
Arbuck, SG .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1998, 1400 (1-3) :107-119